Abstract
In Vitro Drug Response Profiling in BCP- and T-ALL Primary Samples Adds a Robust Functional Layer Enabling Optimized Guidance of Individualized Therapy in Relapsed and Refractory Pediatric Acute Leukemia Patients
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have